Novartis(NVS) - 2023 Q4 - Earnings Call Presentation

Financial review U NOVARTIS | Reimagining Medicine Share buybacks >USD 32bn 2018-2023 New USD 15bn SBB commenced in Jul 2023 Novartis Q4 Results | January 31, 2024 29 Content Click below to navigate through the document • Completed the separation of Sandoz to create an independent company by way of 100% spin-off (Oct 4, 2023) U NOVARTIS | Reimagining Medicine Novartis Sandoz Content Click below to navigate through the document Conclusions 1. Proposal to shareholders at the 2024 Annual General Meeting, takin ...